Thema
Letter
Comment
3.531
COVID-19
1.534
Case Reports
747
Research Support, Non-U.S. Gov't
649
SARS-CoV-2
488
Antiviral Agents
206
Hydroxychloroquine
196
4QWG6N8QKH
193
EC 3.4.15.1
158
Peptidyl-Dipeptidase A
158
Coronavirus
148
Angiotensin-Converting Enzyme 2
147
EC 3.4.17.23
147
Research Support, N.I.H., Extramural
135
ACE2 protein, human
133
Antibodies, Viral
132
RNA, Viral
120
coronavirus
115
Aerosols
111
Review
108
Anticoagulants
104
Antibodies, Monoclonal, Humanized
96
Biomarkers
95
Cytokines
87
Covid-19
86
Clinical Trial Protocol
85
Pandemic
83
Observational Study
82
Multicenter Study
77
Randomised controlled trial
73
Comparative Study
70
Immunoglobulin G
69
Angiotensin-Converting Enzyme Inhibitors
67
Immunosuppressive Agents
67
83905-01-5
64
Azithromycin
64
COVID-19 Vaccines
63
protocol
63
Spike Glycoprotein, Coronavirus
60
Fibrin Fibrinogen Degradation Products
56
fibrin fragment D
56
Anti-Inflammatory Agents
55
Adrenal Cortex Hormones
54
O3J8G9O825
54
Ritonavir
54
tocilizumab
54
Angiotensin Receptor Antagonists
53
I031V2H011
53
Lopinavir
53
mehr ...